Results 1 to 10 of about 4,777,523 (330)

Genetic Features of Metachronous Esophageal Cancer Developed in Hodgkin's Lymphoma or Breast Cancer Long-Term Survivors: An Exploratory Study. [PDF]

, 2015
Background Development of novel therapeutic drugs and regimens for cancer treatment has led to improvements in patient long-term survival. This success has, however, been accompanied by the increased occurrence of second primary cancers.
Alfieri, R, Amadori, Alberto, Boldrin, E, Cagol, M, Cappellesso, Rocco, Castoro, C, Chiarion Sileni, V, Fassan, Matteo, Rugge, Massimo, Rumiato, E, Ruol, A, Saggioro, D.   +11 more
core   +21 more sources

Current Status and Future Prospects for Esophageal Cancer

Cancers, 2023
Simple Summary Over 500,000 individuals died due to esophageal cancer (EC) worldwide in 2020. More than four decades of etiological research have predominantly focused on the esophageal squamous cell carcinoma (ESCC) subtype, which accounts for 80% of EC
Mahdi Sheikh, G. Roshandel, V. McCormack, R. Malekzadeh   +3 more
semanticscholar   +1 more source

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.

New England Journal of Medicine, 2021
BACKGROUND No adjuvant treatment has been established for patients who remain at high risk for recurrence after neoadjuvant chemoradiotherapy and surgery for esophageal or gastroesophageal junction cancer.
R. Kelly, J. Ajani, J. Kużdżał, T. Zander, E. Van Cutsem, G. Piessen, G. Mendez, J. Feliciano, S. Motoyama, A. Lièvre, H. Uronis, E. Elimova, C. Grootscholten, K. Geboes, S. Zafar, S. Snow, A. Ko, K. Feeney, M. Schenker, Piotr Kocoń, Jenny Zhang, Lili Zhu, M. Lei, Prianka Singh, K. Kondo, J. Cleary, M. Moehler   +26 more
semanticscholar   +1 more source

Clinicopathological Features of Early-Stage Esophageal Carcinosarcoma

Case Reports in Gastroenterology, 2022
Esophageal carcinosarcoma (EC) is a rare malignant tumor, accounting for 0.5–2.8% of esophageal cancers. Most are advanced cancers that are detected as polypoid lesions and are treated with multidisciplinary therapy with a focus on surgery.
Kentaro Kubo, Junya Oguma, Daichi Utsunomiya, Kyohei Kanematsu, Yusuke Fujii, Daisuke Kurita, Koshiro Ishiyama, Seiichiro Abe, Shigeki Sekine, Hiroyuki Daiko   +9 more
doaj   +1 more source

Thoracoscopic esophageal drainage for tracheal compression due to mucocele after esophagogastric bypass: a case report

Surgical Case Reports, 2023
Background Esophagogastric bypass is performed for esophageal strictures. Mucus retention, known as mucocele, sometimes occurs at the stricture oral side of the remnant esophagus. It is often asymptomatic and is expected to be naturally decompressed, but
Takeshi Yamashita, Koji Otsuka, Satoru Goto, Tomotake Ariyoshi, Kentaro Motegi, Masahiro Kohmoto, Akira Saito, Koichiro Fujimasa, Yoshihito Sato, Rei Kato, Tetsuo Sawatani, Masahiko Murakami   +11 more
doaj   +1 more source

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

Journal of Clinical Oncology, 2021
PURPOSE Preoperative chemoradiotherapy according to the chemoradiotherapy for esophageal cancer followed by surgery study (CROSS) has become a standard of care for patients with locally advanced resectable esophageal or junctional cancer.
B. Eyck, J. V. van Lanschot, M. Hulshof, B. J. van der Wilk, J. Shapiro, P. van Hagen, M. I. van Berge Henegouwen, B. Wijnhoven, H. V. van Laarhoven, G. Nieuwenhuijzen, G. Hospers, J. Bonenkamp, M. Cuesta, R. Blaisse, O. Busch, G. Creemers, C. Punt, J. Plukker, H. Verheul, E. S. Spillenaar Bilgen, M. V. D. van der Sangen, T. Rozema, F. T. ten Kate, J. Beukema, A. Piet, C. M. Van rij, J. Reinders, H. Tilanus, E. Steyerberg, A. van der Gaast   +29 more
semanticscholar   +1 more source

Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040

Thoracic Cancer, 2022
Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with
Chunquan Liu, Yunlei Ma, Qi Qin, Pei‐Hao Wang, Yi Luo, Peng‐Fei Xu, Yong Cui   +6 more
semanticscholar   +1 more source

Tissue Oxygen Saturation during Gastric Tube Reconstruction with Cervical Anastomosis for Esophagectomy: A Case Series

Journal of Investigative Surgery, 2022
Background One cause of anastomotic leakage after radical esophagectomy is blood flow insufficiency at the cervical anastomosis site. . Methods Eighteen patients, who underwent radical esophagectomy with gastric tube reconstruction, were studied.
Kenjiro Ishii,, Yasuhiro Tsubosa,, Shuhei Mayanagi,, Masazumi Inoue,, Ryoma Haneda,   +4 more
doaj   +1 more source

Focal amplifications are associated with chromothripsis events and diverse prognoses in gastric cardia adenocarcinoma

Nature Communications, 2021
The role of focal amplifications and extrachromosomal DNA (ecDNA) is unknown in gastric cardia adenocarcinoma (GCA). Here, the authors identify frequent focal amplifications and ecDNAs in Chinese GCA patient samples, as well as the potential associations
Xue-Ke Zhao, Pengwei Xing, Xin Song, Miao Zhao, Linxuan Zhao, Yonglong Dang, Ling-Ling Lei, Rui-Hua Xu, Wen-Li Han, Pan-Pan Wang, Miao-Miao Yang, Jing-Feng Hu, Kan Zhong, Fu-You Zhou, Xue-Na Han, Chao-Long Meng, Jia-Jia Ji, Xingqi Chen, Li-Dong Wang   +18 more
doaj   +1 more source

Esophageal cancer in China: Practice and research in the new era

International Journal of Cancer, 2022
China, as the one of the largest developing countries in the world and with about one‐fifth of the global population, is bearing an increasing burden on health from cancer.
Hongcheng Zhu, Xiao Ma, T. Ye, Honggang Wang, Zezhou Wang, Qi Liu, K. Zhao   +6 more
semanticscholar   +1 more source